Home / Cancer and immune system / Ipilimumab
ATC L01FX04 · Other Monoclonal Antibodies and Antibody Drug Conjugates · updated 2 Nov 2026
Ipilimumab shortage
As of 2 Nov 2026, Ipilimumab has a reported shortage in 1 of the 16 countries we track (Switzerland), covering 2 products from 1 company.
Is there an Ipilimumab shortage?
Yes. As of 2 Nov 2026, Ipilimumab is reported short in 1 of the 16 countries we track: Switzerland. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Bristol Myers Squibb BMY · NYSE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | YERVOY Inf Konz 200 mg/40ml Durchstf | Bristol-Myers Squibb SA | 12 Feb 2026 | not given | Not stated |
| CH | YERVOY Inf Konz 50 mg/10ml Durchstf | Bristol-Myers Squibb SA | 12 Feb 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Ipilimumab shortage?
Yes. As of 2 Nov 2026, Ipilimumab is reported short in 1 of the 16 countries we track: Switzerland. No company has given a return date.
When will Ipilimumab be back in stock?
No return date has been given; Switzerland: no date given. These are company estimates reported to each authority.
Why is Ipilimumab in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Ipilimumab shortages?
Bristol Myers Squibb.